Dr. Vikram Deep Monga

Contact Info
Dr. Vikram Deep Monga
9780545690
5202, Street No 6, Nai basti, Malvia nagar
Dr. Vikram Deep Monga

Assistant Professor, Department of Pharmaceutical Sciences and Natural Products, School of Health Sciences

Qualification
  • Post Doctorate from Midwestern University, Chicago, USA (2009)
  • Ph.D. in Medicinal Chemistry, NIPER, Mohali, India (2008)
  • M.S. (Pharm.) in Medicinal Chemistry, NIPER, Mohali (2002)
  • B.Pharm. Guru Nanak Dev University, Amritsar, Punjab, India (2001)
Experience
Teaching Experience:12 Yrs;    Research Experience: 18 Yrs;     Administrative Experience: 9 Yrs

Experience Details

           Period     Position Held            Organization/Institute
24-12-2021-Current Assistant Professor Central University of Punjab, Bathinda, Punjab
16-11-2017 to 24-12-2021 Professor and Head ISF College of Pharmacy, Moga, Punjab
30-08-2017 to 14-11-2017 Professor PDM University, Bahadurgarh, Haryana
06-02-2012 to 24-08-2017 Professor and Head RITS, Sirsa, Haryana
04-08-2009 to 14-05-2011 Associate Professor ISF College of Pharmacy, Moga, Punjab
15-12-2007 to 09-08-2008 Assistant Professor ISF College of Pharmacy, Moga, Punjab
Any Other Experience

Dr. Reddy's Laboratories, Hyderabad, 6.0 months (Jan-Aug 2003)

 

Research Area

1. Medicinal Chemistry and Drug discovery  

2. Peptides, Functionalized Amino Acids and Novel/New Heterocycles as Therapeutic Candidates

3. Natural product Chemistry/Drug Design

Research Interests

- Design synthesis, biological evaluation and in silico studies of Novel/New chemical entities targeting

     - Neurological disorders (Epilepsy, Alzheimer, Antidepressants)

     - Metabolic disorders (Obesity, Diabetes)

     - Infectious diseases (Antibacterial, Antitubercular, Antimalarial)

- Therapeutic Peptides, functionalized amino acids and Heterocyclic small molecules

- Isolation, Characterization and Synthetic modification of Natural Products/Leads

Research Grants/Projects

- Design and Synthesis of Disubstituted Rhodanine Based Pancreatic Lipase Inhibitors as Anti-Obesity Agents - Funded by Central University of Punjab - 3.00 Lakhs

- Young Investigator Fellowship (13.8 Lacs as Principal Investigator) for the proposal submitted under “SERC Fast Track Proposals for Young Scientists Scheme” from the Department of Science and Technology (DST), India, 2005-2008

Professional Affiliation

- Approved as “Certified trainer of the trainer” for the qualification pack Quality control chemist (Trainer ID 4093) by National Skill Development Cooperation, India.

- Registered as Pharmacist with Punjab State Pharmacy Council

- Life member of Indian Peptide Society

Professional Recognition/Awards/Scholarships
  • Chair Person in One day Workshop on  “Funding Opportunities For Research, Innovation & Career Development” Under Aegis of AICTE (SWAYAM) held at ISF College of Pharmacy, Moga, Punjab, India, on 22 July, 2018
  • Resource person at conference Recent Advances in Oral Controlled Drug Delivery System” held at College of Pharmacy at Bela (Ropar) in collaboration with Punjab Technical University, Jalandhar, India on 1st October, 2011
  • Received “Midwestern University” Chicago, Postdoctoral Research Fellowship from 2008-2009  
  • Awarded prestigious “Endeavour Research Fellowship” by Australian Government (2007):  Thankfully declined
  • Awarded the first prize for the best Oral Paper Presentation in the symposium entitled “FIRST INDIAN PEPTIDE SYMPOSIUM IPS-2007” organized by Indian peptide Society held at Hyderabad from 22 – 23rd February 2007.
  • Senior Research Fellow (2004-2005) in the Dept. of Med. Chem. NIPER, SAS Nagar, Mohali, Punjab 160062.
  • Received International Travel Award from “American Peptide Society” to attend 20th American Peptide Symposium held at Montreal, Canada from 26-30 June 2007.
  • Received Travel Award form CSIR, India 2007 to attend American Peptide Symposium held at Monteral, Canada.
  • Qualified GATE in Pharmaceutical Sciences in 2001 (GATE score 421, AIR = 717)

 

  • Reviewer of Journals

 - European Journal of Medicinal Chemistry

 - Bioorganic Chemistry

 - Bioorganic and Medicinal Chemistry

 - Bioorganic and Medicinal Chemistry Letters

 - Chemical Biology and Drug Design

 - Medicinal Chemistry Research

 - Journal of Enzyme Inhibition and Medicinal Chemsitry

 - Journal of Molecular Structure

- Journal of Medicinal Chemistry

 - Main Group Chemistry

 - Journal of Molecular Structure

Research Collaboration

Dr. Atish Paul, Associate Professor, BITS, Pilani

Dr. Rajiv Taliyan, Associate professor, BITS, Pilani

National Institute of Infectious Disease, Bethesda, USA

Dr. D.P. Rajani, Microcare Laboratory, Gujrat

Dr. Alok Sharma, ISF College of Pharmacy, Moga

Publications

ORCID ID: 0000-0003-4004-6241

Web of Science ID: AAD-2494-2022

Scopus ID: 6602625249

Google Scholar Profile: https://scholar.google.com/citations?user=nHAv1loAAAAJ&hl=en

International Papers

  1. Singh S, Sharma A, Monga V*, Bhatia R. Compendium of naringenin: Potential sources, analytical aspects, chemistry, nutraceutical potentials and pharmacological profile. Critical Reviews in Food Science and Nutrition, 2022, 1-32, Impact Factor 11.20, ISSN: 1549-7852 (web)https://doi.org/10.1080/10408398.2022.2056726
  2. Singh, S; Monga, V*; Bhatia, R. Impact of Fluorescence based Analytical Techniques in Cancer Management: An Update. Current Analytical Chemistry, 2022, 18, 1-5, IF: 2.37, ISSN: 1875-6727, https://doi.org/10.2174/1573411018666220519105216
  3. Kumari K, Singh G, Pradhan T, Bhurta D, Monga V*. The medicinal perspective of 2,4‐thiazolidinediones based ligands as antimicrobial, antitumor and antidiabetic agents: A review. Archive der Pharmazie, 2022; e2100517, 1-36, Impact Factor 4.61, ISSN: 1875-6190, https://doi.org/10.1002/ardp.202100517  
  4. Singh, K.; Bhatia, R.; Kumar, B.; Singh, G, Monga, V*. Design strategies, Chemistry, and therapeutic insights of multi-target directed ligands as antidepressant agents. Current Neuropharmacology, 20(7), 2022, 1329-1358. Impact Factor 7.70, ISSN: 0223-5234.  DOI:10.2174/1570159X19666211102154311
  5. Pradhan, T.; Gupta, G.; Singh, G, Monga, V*. Aurora kinase inhibitors as potential anticancer agents: Recent advances. European Journal of Medicinal Chemistry, 221, 2021, 113495. Impact Factor 6.5, ISSN: 0223-5234.  https://doi.org/10.1016/j.ejmech.2021.113495   
  6. Yadav, AK, Kumar, S, Monga V*. Progress in the Development of Potential Therapeutics and Vaccines against COVID-19 Pandemic. Acta Scientific Pharmaceutical Sciences, 5(6), 2021, 45-62, IF = 1.02, ISSN: 2581-5423.
  7. Gaba, S.; Saini, A.; Singh, G, Monga, V*. An insight into the medicinal attributes of berberine derivatives: A review. Bioorganic & Medicinal Chemistry, 38, 2021, 116143. Impact Factor 3.64, ISSN: 0968-0896.  https://doi.org/10.1016/j.bmc.2021.116143    
  8. Rulhania, S.; Kumar, S.; Nehra, B.; Gupta, GD, Monga, V*. An insight into the medicinal perspective of synthetic analogs of imidazole. Journal of Molecular Structure, 1232, 2021, 129982. Impact Factor: 3.19, ISSN: 0022-2860. https://doi.org/10.1016/j.molstruc.2021.129982
  9. Shubham Kumar, Sandeep Rulhania, Shalini Jaswal, Monga, V*. Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors. European Journal of Medicinal Chemistry, 2021, 209, 112923. Impact Factor: 6.5, ISSN: 0223-5234. https://doi.org/10.1016/j.ejmech.2020.112923
  10. Jaswal, S.; Nehra, B.; Rulhania, S.; Kumar, B.; Singh, G.; Monga, V*. Recent advancements in the medicinal chemistry of bacterial type II topoisomerase inhibitors. Bioorganic Chemistry, 104, 2020; 104266, IF: 5.28, doi.org/ 10.1016/j.bioorg.2020.104266
  11. Nehra, B.; Rulhania, S.; Jaswal, S.; Kumar, B.; Singh, G.; Monga, V*. Recent Advancements in the Development of Bioactive Pyrazoline Derivatives. European Journal of Medicinal Chemistry, 205, 2020, 112666. Impact Factor: 6.5, ISSN: 0223-5234. doi.org/10.1016/j.ejmech.2020.112666
  12. Kumar, R.; Bhatia, R.; Singh, G.; Kumar, B.; Mehan, S.; Monga, V*. Design, Synthesis and Neuropharmacological Evaluation of New 2,4-Disubstituted-1,5-Benzodiazepines as CNS Active Agents. Bioorganic Chemistry, 101, 2020. 104010, IF: 5.28, ISSN: 0045-2068; doi.org/10.1016/j.bioorg.2020.104010
  13. Devi, S.; Singh, G.; Monga, V*. Recent Advance in the Synthetic Chemistry of 1,5-Benzothiazepines: A Minireview. Journal of Heterocyclic Chemistry, 2020, IF: 2.19,  ISSN:1943-5193, https://doi.org/10.1002/jhet.4062
  14. Sharma, S.; Kumar, D.; Singh, G.; Monga, V.; Kumar, B. Recent advancements in the development of heterocyclic anti-inflammatory agents. European Journal of Medicinal Chemistry, 200, 2020, 112438. IF: 6.5, ISSN: 0223-5234; https://doi.org/10.1016/j.ejmech.2020.112438.  
  15. Kumar, D.; Sharma, S.; Kalra, S.; Singh, S.; Monga, V.; Kumar, B. Medicinal perspective of indole derivatives: recent developments and structure-activity relationship studies. Current Drug Targets, 21, 2020, 864-891. IF: 3.46, ISSN: 1873-5592; doi:10.2174/1389450121666200310115327.
  16. Arora N.; Dhiman P.; Kumar S.; Singh G.; Monga, V. Recent advances in the synthetic and medicinal perspective of benzodiazepines. Bioorganic Chemistry, 97, 2020, 103668. IF: 5.28; ISSN: 0045-2068; doi.org/10.1016/j.bioorg.2020.103668.
  17. Bansal, G.; Singh, S.; Monga, V.; Thanikachalam, P.V.; Chawla, P. Synthesis and biological evaluation of thiazolidine-2,4-dione-pyrazole conjugates as antidiabetic, anti-inflammatory and antioxidant agents, Bioorganic Chemistry,  92, 2019, 103271.  IF: 5.28;  ISSN: 0045-2068; https://doi.org/10.1016/j.bioorg.2019.103271.
  18. Dhiman P.; Arora N.; Thanikachalam PV.; Monga V. Recent advances in the synthetic and medicinal perspective of quinolones: A review. Bioorganic Chemistry, 92, 2019, 103291. IF: 5.28; ISSN: 0045-2068; https://doi.org/10.1016/j.bioorg.2019.103291. 
  19. Garg, V.; Puniyakoti, VT.; Maurya, R.; Monga, V. An insight into the medicinal perspective of synthetic analogs of indole: A review. European Journal of Medicinal Chemistry, 2019, 180, 562-612. ISSN:  0223-5234, IF: 6.5,  doi.org/10.1016/j.ejmech.2019.07.019.
  20. Chauhan D.; George, G.; S.N.C. Sridhar.; Bhatia, R.; Paul, A.;  Monga, V*. Design, synthesis, biological evaluation, and molecular modelling studies of rhodanine derivatives as pancreatic lipase inhibitors. Archive der Pharmazie, 2019, 352(10), e1900029, ISSN: 1521-4184, IF: 3.75, doi.org/10.1002/ardp.201900029.
  21. Nayak, S. K.; Khatik, G.L.; Narang, R.; Monga, V.; Chopra, H.K. p53-Mdm2 interaction inhibitors as novel nongenotoxic anticancer agents. Current Cancer Drug Targets, 18(8), 749-772, 2018. ISSN: 1568-0096; IF: 3.43, doi.org/10.2174/ 1568009617666170623111953. 
  22. Mehan, S.; Monga, V.; Kukkar, U.  Clinical Therapeutic Strategies to Ameliorate the Mitochondrial ETC Complexes Dysfunctions in Autism: First Time from India. Virology & Immunology, 1(5), 2017, 000125. Impact Factor: 2.0
  23. Shridhar, S.N.C.; Bhurta, D.; Kantiwal, D.; George, G.; Monga, V.;* Paul, A.* Design, Synthesis, Biological Evaluation and Molecular Modelling Studies of Novel Diaryl Substituted Pyrazolyl Thiazolidinediones as Potent Pancreatic Lipase Inhibitors. Bioorganic and Medicinal Chemistry Letters, 27(16), 2017, 3749-3754. doi.org/10.1016/j.bmcl.2017.06.069, ISSN: 0960-894X; Impact Factor: 2.82
  24. Monga, V.;* Goyal, K.; Steindel, M.; Rajani, D.P.; Rajani, S. Synthesis, and evaluation of new chalcones, derived pyrazolines and cyclohexenone derivatives as potent antimicrobial, antitubercular and antilieshmanial agents. Medicinal Chemistry Research, Springer, ISSN (printed): 1054-2523. ISSN (electronic): 1554-8120, 2014, 23, 2019-2032; doi.org/10.1007/s00044-013-0803-1 (Published online 1 October 2013), Springer, Impact Factor: 1.96 
  25. Malhotra, M.; Monga, V.; Sharma, R.; Sahu, K.; Sharma, G.; Jain, J.; Deep. A. Synthesis, Characterization of (Z)-N-(1-(2-(2-Amino-3-((dimethylamino)methyl) phenyl)-5-phenyl-1,3,4-oxadiazol-3-(2H)-yl)ethanone analogues as potent antimicrobial and hydrogen peroxide scavenging agents. Bentham Science, ISSN (printed): 1573-4064, Medicinal Chemistry, Aug 2013, 9(5), 710-717, ISSN: 1875-6638; doi.org/10.2174/ 1573406411309050011, Bentham Science, IF: 2.74.
  26. Malhotra, M.; Monga, V.; Sharma, S; Jain, J.;Samad, A.; Stables, J,; Deep. A. Synthesis, characterization and pharmacological evaluation of (E)-N′-(substituted-benzylidene) isonicotinohydrazide derivatives as potent anticonvulsant agents. Medicinal Chemistry Research, Springer, Sep 2012, 21(9), 2145-2152, IF: 1.96, ISSN (electronic): 1554-8120, doi.org/10.1007/s00044-011-9739-5.
  27. Yadav, N.; Malhotra, M.; Monga, V.; Sharma, S; Jain, J.;Samad, A.; Stables, J,; Deep. A. Synthesis, characterization, and pharmacological evaluation of new GABA analogs as potent anticonvulsant agents. Medicinal Chemistry Research, Springer, ISSN (printed): 1054-2523. ISSN (electronic): 1554-8120, Sep, 2012, 21(9), 2208-2216, doi.org/10.1007/s00044-011-9743-9 (Published online 19 July 2011). Impact Factor: 1.96
  28. Monga, V.; Meena, C. L.; Rajput, S. K.; Pawar, C.; Sharma, S. S.; Lu, X.; Gershengorn, M.C.; Jain, R. Synthesis, receptor binding and CNS pharmacological studies of new thyrotropin-releasing hormone (TRH) analogs. Chem Med Chem.  Wiley, ISSN: 1860-7187, March 2011, 6(3), 531-543. Impact Factor: 3.46
  29. Malhotra, M.; Sharma, R.; Monga, V.; Deep, A.; Sahu, K.; Samad, A. Synthesis, characterization of (E)-N’-(substituted-benzylidene) isonicotinohydrazide derivatives as potent anti-tubercular agents. Letters in Drug Design & Discovery, Bentham Science, ISSN: 1875-628X (Online), July 2011, 8(6) 575-579. Impact Factor: 1.15
  30. Rajput, S. K.; Singh, J.N.; Ingole, S.; Jain, G.; Kaur, N.; Monga, V.; Meena, C. L.; Jain, R.; Sharma, S. S. Neuropharmacological profile of L-pGlu-(1-benzyl)-L-His-L-ProNH2, a newer thyrotropin-releasing hormone (TRH) analog: Effect on seizure models, sodium current, cerebral blood flow and behavioural parameters. Epilepsy Research, Elsevier, ISSN: 0920-1211, Dec 2009, 87, 223-233. Impact Factor: 3.04
  31. Rajput, S. K.; Krishnamoorthy, S.; Pawar, C.; Kaur, N.; Monga, V.; Meena, C. L.; Jain, R.; Sharma, S. S. Antiepileptic potential and behavioural profile of L-pGlu-(2-propyl)-L-His-L-ProNH2, a newer thyrotropin-releasing hormone (TRH) analog. Epilepsy and Behaviour, Elsevier, Jan 2009, 14, 48-53. ISSN: 1525-5050, Impact Factor: 2.93
  32. Monga, V.; Meena, C. L.; Kaur, N.; Kumar, S.; Pawar, C.; Sharma, S. S.; Jain, R. Facile synthesis of N-α-Boc-1,2-dialkyl-L-Histidines: Utility in the synthesis of thyrotropin-releasing-hormone (TRH) analogs and evaluation of CNS activity. Journal of Heterocyclic Chemistry, Wiley, ISSN: 1943-5193, Nov-Dec 2008, 45, 1603-1608.  Impact Factor: 2.19
  33. Monga, V.; Meena, C. L.; Kaur, N.; Jain, R. Chemistry and biology of thyrotropin-releasing hormone (TRH) and its analogs. Current Medicinal Chemistry, Bentham Science, ISSN: 0929-8673 (Print), ISSN: 1875-533X (Online), Feb 2008, 15 (26), 2718-33. Impact Factor: 4.53
  34. Kadam, R. U.; Chawan, A. G; Monga, V.; Kaur, N.; Jain, R.; Roy, N. Selectivity based QSAR approach for screening and evaluation of TRH analogs for TRH-R1 and TRH-R2 receptor subtypes. Journal of Molecular Graphics and Modelling, Elsevier, ISSN: 1093-3263, Oct 2008, 27, 309-320. Impact Factor: 2.51
  35. Nayak, S.K; Monga, V; Kaur, N; Jain, R. Facile regiospecific synthesis of N-α, N-1(τ)-dialkyl-L-Histidines. Journal of Heterocyclic Chemistry Wiley, ISSN: 1943-5193, Nov/Dec 2007, 44, 1265-1269. Impact Factor: 2.19
  36. Kaur, N.; Monga, V.; Lu, X.; Gershengorn, M.C.; Jain, R. Modifications of the pyroglutamic acid and histidine residues in thyrotropin-releasing hormone (TRH) yield analogs with selectivity for TRH receptor type 2 over type 1. Bioorganic Medicinal Chemistry Elsevier, ISSN: 0968-0896, Jan 2007, 15, 433-443. Impact Factor: 3.64
  37. Nayyar, A; Monga, V; Malde, A; Coutinho, E; Jain, R. Synthesis, Anti-tuberculosis Activity and 3D-QSAR Study of 4-(Adamantan-1-yl)-2-Substituted Quinolines. Bioorganic and Medicinal Chemistry Elsevier, ISSN: 0968-0896, Feb 2007, 15, 626-640. Impact Factor: 3.64
  38. Kaur, N.; Monga, V.; Josan, J.S.; Lu, X.; Gershengorn, M.C.; Jain, R. Synthesis, Receptor binding and Activation Studies of N(1)-alkyl-L-Histidine containing Thyrotropin-Releasing Hormone Analogues. Bioorganic and Medicinal Chemistry Elsevier, ISSN: 0968-0896, Sep 2006, 14, 5981-5988. Impact Factor: 3.64
  39. Engel, S.; Neumann, S.; Kaur, N.; Monga, V.; Jain, R.; Northup, J.; Gershengorn, M.C. Low affinity analogs of Thyrotropin-Releasing Hormone are super-agonists. Journal of Biological Chemistry, American society of biochemistry & molecular biology, Print ISSN 0021-9258, Online ISSN 1083-351X, May 2006, 281(19), 13103-13109. Impact Factor: 5.15
  40. Monga, V.; Nayyar, A.; Vaitilingam, B.; Palde, P.B.; Jhamb, S.S.; Kaur, S.; Singh, P.P. Jain, R. Ring-substituted quinolines. Part 2. Synthesis and antimycobacteial activities of ring-substituted quinolinecarbohydrazide and ring-substituted quinolinecarboxamide analogs. Bioorganic and Medicinal Chemistry Elsevier, ISSN: 0968-0896, Dec 2004, 12, 6465-6472. Impact Factor: 3.64
  41. Kaur, N.; Monga, V.; Jain, R. Facile one-step synthesis of N-α-Boc-1-alkyl-L-histidines. Tetrahedron Letters Elsevier, ISSN: 0040-4039, Sep 2004, 45, 6883-6885. Impact Factor: 2.41
  42. Vaitilingam, B.; Nayyar, A.; Palde, P.B.; Monga, V.; Jain, R.; Kaur, S.; Singh, P.P. Synthesis and antimycobacterial activities of ring-substituted quinolinecarboxylic acid/ester analogues. Part 1. Bioorganic and Medicinal Chemistry Elsevier, ISSN: 0968-0896, Aug 2004, 12, 4179-4188. Impact Factor: 3.64
Articles
  1. Yadav, AK.; Singh, G.; Monga, V. Design synthesis and antibacterial evaluation of arylidene derivatives of rhodanine-3-hexanoic acid. Pharmaspire, 13(1), 2021, 1-6, ISSN: 2321-4732.
  2. Arora, N.; Devi, V.; Monga, V*. Antibacterial properties of new 5-substituted derivatives of rhodanine-3-propanoic acid. Pharmaspire, 12(1), 2020, ISSN: 2321-4732.
  3. Singh, G.; Monga, V. Synthesis, structural identification, and biological evaluation of naphthalene-based pyrimidines. Pharmaspire, 11(3), 2019, ISSN: 2321-4732.
  4. Mehan, S.; Monga, V.; Rani, M.; Dudi, R.; Ghimire, K. Neuroprotective effect of solanesol against 3-nitropropionic acid‑induced Huntington’s disease‑like behavioral, biochemical, and cellular alterations: Restoration of coenzyme‑Q10-mediated  mitochondrial dysfunction. Ind. J. Pharmacol. 50(6), 2018, 2236-2242. doi: 10.4903/ijp.IJP_11_18. ISSN: 0253-7613; Impact Factor (1.04)
  5. Nayak, S. K.; Khatik, G.L.; Narang, R.; Monga, V. Role of Mdm2 cascade in Human Cancers. Res. J. Pharm. and Tech. 10(7), 2017, 2236-2242. doi: 10.5958/0974-360X.2017.00396.1. ISSN: 0974-360X; Impact Factor (0.14)
  6. Singh, H; Monga, V*. Synthesis, antibacterial, antifungal and antioxidant evaluation of some new thiazole clubbed oxadiazole derivatives. Indian J. Heterocy. Chem. 27(01), 2017, 51-57. ISSN:2456-4311; Impact Factor (0.16)
  7. Singh, G; Nayak, SK; Monga, V*. Synthesis and biological screening of some new 1,5-benzodiazepine derivatives as promising antibacterial and antitubercular agents.  Indian J. Heterocy. Chem. 27(02), 2017, 143-149. ISSN:2456-4311; Impact Factor (0.16)
Books
 
Book Chapters
  1. Monga, V; Dhiman, P. Therapeutic peptides as potential Central Nervous System Active Agents, In; Animal Screening Basics of Drug Discovery Vol II, Chapter, 1st Edition, Paging Publishers, New Delhi, 375, 2019 (ISBN: 979-87- 93630-97-2)
  2. Rajput, SK; Kumar, A; Monga, V; Nimesh H. Investigation Tools Principles and Applications: General Considerations, In: Animal Screening Basics of Drug Discovery, Chapter 3, 1st Edition, Paging Publishers, New Delhi, 22, 2018 (ISBN: 978-81-93630-91-4).
Research Guidance

M.Pharm Guidance: 28

Conference/ Workshops/Seminars Attended
National
  1. Participated in Two day National conference on “54th Annual conference of the Indian hospital pharmacists association” at ISFCP on 13th -14th September 2019.
  2. Participated in One day National conference on  “Advanced bioanalytical techniques, artificial intelligence and health sciences” organised by  I.S.F. College of Pharmacy in collaboration with Society of pharmaceutical & research held at I.S.F. College of Pharmacy, Moga, Punjab, India, on 24 December, 2018
  3. Participated in 70th IPC National Conference on “Pharma vision 2030: Indian Pharma Industry-A Global Leader” held at Amity University, Noida, Haryana, India, from 21-23th December, 2018.
  4. Participated in Workshop-cum-seminar on “BLS-ACLS and recent trends in Health Economics and Outcome Research” held at ISF College of Pharmacy, Moga, Punjab, India, on 11 August, 2018.
  5. Participated and Chair Person in One day Workshop on  “Funding Opportunities For Research, Innovation & Career Development” Under Aegis of AICTE (SWAYAM) held at ISF College of Pharmacy, Moga, Punjab, India, on 22 July, 2018.
  6. Participated in 69th IPC National Conference on “Skill and Will to Make & Serve Quality Pill” held at Chitkara University, Rajpura Punjab, India, from 22-24th December, 2017.
  7. Participation and poster presentation in the 3rd Annual conference of APTI-Haryana State Branch, on theme “Current Scenario and Challenges in Industrial-Academia Interaction in Pharmaceutical sector” held at JCDM College of Pharmacy, Sirsa, Haryana from 11-12 November, 2016.
  8. Participation and poster presentation in the APTI sponsored conference entitled “Challenges and Opportunities in Drug Design and Development” held at JCDM College of Pharmacy, Sirsa, Haryana on 23 April 2016.
  9. Participated in National Seminar on “Recent Advances in Oral Controlled Drug Delivery System” as a resource person (Judge for poster session), held at College of Pharmacy at Bela (Ropar) in collaboration with Punjab Technical University, Jalandhar, India on 1st October, 2011.
  10. Participated in AICTE Sponsored National Seminar on Rational Use and Clinical Trial of Drugs, held at I.S.F. College of Pharmacy at Moga, India from 26-27th March, 2011.
  11. Participated and member of organizing committee in 47th Annual Conference of IHPA, 2011, Role of Pharmacist in Rational Use And Clinical Trial of Drugs, held at I.S.F. College of Pharmacy at Moga, India from 30-31st Oct, 2010.
  12. Participated and member of organizing committee in  Silver Jubilee Conference of Indian Pharmacy Graduates Association (IPGA)-2009, Challenges and Opportunities for Pharmacy Graduates in 21st Century, at ISF College of Pharmacy at Moga, India from 7-8th Nov, 2009.   
  13. Participated in the DST sponsored workshop on “Green Chemistry” held at National Institute of Pharmaceutical Education & Research (NIPER), Mohali, India from 3-4th September 2007.
International
  1. AICTE Sponsored International Conference on “Pharmaceutical Drug Discovery & Development-Future Prospects” held at Rajendra Institute of Technology & Sciences, Sirsa, Haryana, India from 28th-29th July 2012.
  2. Participation and poster presentation in the symposium entitled “20th AMERICAN PEPTIDE SYMPOSIUM, PEPTIDES FOR YOUTH” organized by American Peptide Society held at Montreal,  Quebec, Canada from 26–30th  June 2007.
  3. Oral Paper presentation and participation in the symposium entitled “FIRST INDIAN PEPTIDE SYMPOSIUM IPS-2007” organized by Indian peptide Society held at Hyderabad, India from    22–23rd February 2007. I have been awarded the first prize for the best oral paper presentation.
  4. Participated and poster presentation in the International Conference on “CURRENT TRENDS IN DRUG DISCOVERY RESEARCH CTDDR-2007” organized by Central Drug Research Institute (CDRI) held at Lucknow, India from 17 - 21st February 2007.
  5. Participated and poster presentation in the IUPAC International Conference on “Biodiversity and Natural Products: Chemistry and Medical Applications” organized by the Department of Chemistry, University of Delhi, India during January 26-31, 2004.
  6. Participated and poster presentation in the International Conference on “Chemistry Biology Interface: Synergistic New Frontiers” (CBISNF-2004), organized by Dr. B.R. Ambedkar center for Biomedical Research, University of Delhi, India from November 21-26, 2004.
Conference/ Workshops/Seminars Organised
University Level
 
National Level
 
International Level

 

Invited Talks/ Resource Person
- Participated and Chair Person in One day Workshop on “Funding Opportunities For Research, Innovation & Career Development” Under Aegis of AICTE (SWAYAM) held at ISF College of Pharmacy, Moga, Punjab, India, on 22 July, 2018
- Co-coordinating member of AICTE Sponsored International Conference on “Pharmaceutical Drug Discovery & Development-Future Prospects” held at Rajendra Institute of Technology & Sciences, Sirsa, Haryana, India from 28th-29th July 2012.
Resource person in National Seminar on “Recent Advances in Oral Controlled Drug Delivery System”, held at College of Pharmacy at Bela (Ropar) in collaboration with Punjab Technical University, Jalandhar, India on 1st October, 2011.
- Member of organizing committee in 47th Annual Conference of IHPA, 2011, Role of Pharmacist in Rational Use And Clinical Trial of Drugs, held at ISF College of Pharmacy at Moga, India from 30-31st Oct, 2010.
- Member organizing committee in Silver Jubilee Conference of Indian Pharmacy Graduates Association (IPGA)-2009, Challenges and Opportunities for Pharmacy Graduates in 21st Century, at ISF College of Pharmacy at Moga, India from 7-8th Nov, 2009
Patent Filed/ Published
PATENT PUBLISHED
  1. Monga, V.; Jaswal, S.; Sharma, P.; Singh, G. Thiazolidinedione based pancreatic lipase inhibitor as leading anti-obesity agent. WTO Indian Patent Application No. 202111058620, Publication date 22/04/2022. 
  2. Jain, R.; Monga, V.; Kaur, N.; Sharma, S. S.; Kumar, S.; Roy, N.; Majumdar, J.; Agarwal, S.; Pawar, C.; Kadam, R. U.; Chavan, A. CNS effective thyrotropin-releasing hormone analogs. 2006, WTO Indian Patent Application No. 2065/DEL/2006, GRANTED, PATENT No: 270454 (2015)
  3. Jain, R.; Monga, V.; Kaur, N. A process for the synthesis of CNS active thyrotropin-releasing hormone analogs. WTO Indian Patent Application No. 2066/DEL/2006, GRANTED, PATENT No: 269386 (2015)
  4. Roy, N.; Pahwa, S.; Jain, R.; Monga, V.; Sharma, R. K.; Kadam, R. U.; Chavan, A. Novel screening method for antifungal compounds targeted against fungal histidinol dehydrogenase. 2007, WTO Indian Patent Application No. 1117/DEL/2007
  5. Roy, N.; Pahwa, S.; Jain, R.; Monga, V.; Sharma, R. K.; Rohilla, R. K. Ring-modified imidazoles as novel antifungal compounds targeted against fungal histidinol dehydrogenase. 2007, WTO Indian Patent Application No. 1116/DEL/2007